Our company
About us
Business model and strategy
Management
Board of Directors
History
Areas of research
cPLA2a
Pipeline
AVX001 Gel (skin cancer)
AVX420/FOL026 (Kidney- and liverfibrosis)
AVX420 (Leukemia)
FOL056 (Cardiovascular complications)
FOL005 (Wound healing)
FOL005 (Stimulation of hair growth)
Patents
Clinical trials
Investor relations
Why to invest
Press releases
Financial reports
Financial calendar
Event calender
The share
Shareholders
Warrants
Offer documents
Analysis
Presentations
Corporate governance
Articles of Association
Auditor
Previous IR Goldblue
IR Contact
Media
News
Press releases
Coegin News
Contact
Change language
English
Svenska
IR Contact
Tore Duvold
CEO
+45 61 90 50 66
[email protected]